Epigenetic screening to resensitize resistant Diffuse Large B-Cell Lymphoma (DLBCL) cell lines

Facciotto, Chiara (Project manager)
Casado, Julia (Project manager)

Research Programs Unit
Sampsa Hautaniemi / Principal Investigator

Project Details

Description

Drug screening investigating the ability of epigenetic inhibitors to modulate the chromatin structure and reprogram therapy-resistant cancer cells into sensitive ones. Our screening tested 60 epigenetic compounds on four R-CHOP resistant DLBCL cell lines.

Status	Finished
Effective start/end date	04/08/2014 → 11/12/2019

View all

View less

Activities

1 Invited talk

Drug resistance and DLBCL: an epigenetic reprogramming story

Julia Casado Cuervo (Speaker)

13 Dec 2016

Activity: Talk or presentation types › Invited talk